Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs Daily rFSH in Oocyte Donors (TROPIX)
NCT06193135Recruiting
- Sponsor
- IVI
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of corifollitropin alfa in infertility (2 arms), sponsored by IVI. Primary endpoints: Number of total oocytes obtained at 2 years and Number of metaphase II oocytes obtained at 2 years. Started Jul 2025; status: recruiting.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06193135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06193135.